The International Journal of Innovations in Biopharma Production and Quality (IJIBPQ) is a quarterly, peer-reviewed, open-access journal dedicated to publishing high-quality research, reviews, and technical insights in the rapidly evolving field of biopharmaceutical manufacturing and quality assurance.
As the biopharma industry moves toward advanced production systems, quality by design, continuous manufacturing, and regulatory harmonization, IJIBPQ serves as a scholarly platform that bridges the gap between research, industrial application, and regulatory compliance. The journal is designed to address the pressing need for innovative solutions and knowledge-sharing in process development, formulation strategies, production technologies, and quality control systems.
Our Mission
To foster scientific communication and global knowledge exchange by publishing original and impactful research that contributes to excellence and innovation in biopharmaceutical production and quality management.
Our Vision
To be recognized as a leading international resource for researchers, professionals, and organizations committed to advancing sustainable and high-quality biopharma manufacturing practices.
Core Focus Areas
- Biopharmaceutical manufacturing technologies
- Process development and scale-up innovation
- Quality assurance and regulatory science
- GMP and global compliance standards
- Real-time process analytics (PAT)
- Biosimilar production strategies
- Data integrity and digital transformation
- Continuous and modular manufacturing systems
- Packaging, storage, and stability innovations
Who Should Contribute?
- Academic researchers in pharmaceutical and chemical engineering
- Industry professionals in biologics, biosimilars, and vaccines
- Quality control and regulatory affairs experts
- Biotech entrepreneurs and production managers
- Analysts and technologists involved in biopharma innovation
IJIBPQ encourages cross-disciplinary research and welcomes contributions that offer practical insights, experimental breakthroughs, or strategic perspectives relevant to real-world biopharmaceutical production.
